Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago
Available as: 0.9% · 60 ml bottle 0.9% 0.9% 0.9%

Indications & Uses

Scabisad is indicated for:

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

For topical use only. Not for oral, ophthalmic, or intravaginal use.Treatment of Scabies Infestations: The bottle should be shaken well before use The medication should be thoroughly rubbed into the entire body from the neck down to the soles of the feet Patients with balding scalp should also apply the medication to the scalp, hairline, temples, and forehead Sufficient time should be allowed for the medication to absorb into the skin and dry for 10 minutes before dressing Bathing should be avoided for at least 6 hours after application Treatment of Head Lice Infestations: The bottle should be shaken well before use The medicine should be applied thoroughly so that the scalp is completely covered. Then the medication should be applied to dry hair After 10 minutes, the hair should be rinsed with warm water If live lice are observed 7 days after the first treatment, the treatment should be repeated or as directed by the physician. Use in Children & AdolescentsScabies Infestation: The safety and effectiveness of Spinosad Topical Suspension have not been established in pediatric patients less than 4 years of age with scabies infestation.Head Lice Infestation: The safety and effectiveness of Spinosad Topical Suspension for the topical treatment of head lice infestation have been established in pediatric patients 6 months of age and older. Drug Interactions

Side Effects

Most common adverse reactions for: Scabies treatment (>1%) are application site irritation and dry skin Lice treatment (>1%) are application site erythema and ocular erythema

Cautions & Contraindications

Warnings & Precautions

Spinosa Topical Suspension contains benzyl alcohol and is not approved for use in neonates and infants below the age of 6 months.  Systemic exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants when administered intravenously.

Contraindications

No information is available.

Last updated: 18 Aug 2026